Incannex Healthcare Limited, a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and psychedelic medicine therapies for unmet medical needs, announced that Incannex has received approval from Bellberry Human Research Ethics Committee (HREC) to commence a bioavailability/bioequivalence (
